Freedom Biosciences

Freedom Biosciences is a clinical-stage biotechnology platform developing the next generation of viable and effective ketamine and psychedelic therapies. The company’s discovery platform enables them to identify the most effective combinations of chemical compounds to enhance the safety and therapeutic profiles of existing psychedelic treatments. By leveraging known ketamine pharmacology and psychedelic-based therapies, Freedom Biosciences is positioned to uncover potentially revolutionary breakthroughs in the emerging field of psychedelic pharmacology. With a pipeline supported by clinical data and multiple exploratory programs, Freedom Biosciences boasts a diversified portfolio of assets aimed at significantly improving existing psychedelic therapies and transforming the approach to treating mental health indications.